Silvercrest Asset Management’s ROBO Global Healthcare Technology and Innovation ETF HTEC Stock Holding History

Silvercrest Asset Management’s Portfolio HTEC Stock Details HTEC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,000	Closed	-$728K	–	828
2022 Q1	$728K	Hold	20,000	–	–	﹤0.01%	640
2021 Q4	$871K	Hold	20,000	–	–	0.01%	595
2021 Q3	$912K	Hold	20,000	–	–	0.01%	593
2021 Q2	$963K	Hold	20,000	–	–	0.01%	580
2021 Q1	$878K	Hold	20,000	–	–	0.01%	586
2020 Q4	$874K	Hold	20,000	–	–	0.01%	552
2020 Q3	$700K	Hold	20,000	–	–	0.01%	554
2020 Q2	$616K	Buy	+20,000	New	+$562K	0.01%	582

Other funds holding HTEC

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SCM

SOL Capital Management Rockville, Maryland $206M AUM 17.87% 1-Year Est. Return

Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Silvercrest Asset Management's HTEC Position: Q2 2022 in Review

Silvercrest Asset Management sold out of ROBO Global Healthcare Technology and Innovation ETF (HTEC) in Q2 2022, closing a stake of 20,000 shares — an estimated $728K sold.

Silvercrest Asset Management first reported a position in HTEC in Q2 2020 and held it in 8 quarters. The position peaked at $963K in Q2 2021. 38 funds tracked by Wall St. Rank hold HTEC as of Q2 2022.

Silvercrest Asset Management reported no remaining ROBO Global Healthcare Technology and Innovation ETF position as of Q2 2022 after selling out during the quarter.
Silvercrest Asset Management sold 20,000 ROBO Global Healthcare Technology and Innovation ETF shares in Q2 2022, an estimated $728K.
Silvercrest Asset Management first reported a position in ROBO Global Healthcare Technology and Innovation ETF in Q2 2020 and held it in 8 quarters.
Silvercrest Asset Management's ROBO Global Healthcare Technology and Innovation ETF position peaked at $963K in Q2 2021.
38 funds tracked by Wall St. Rank held ROBO Global Healthcare Technology and Innovation ETF as of Q2 2022.

Based on Silvercrest Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.